SHELTON, Conn., April 25, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (NASDAQ: INTS), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and ...
Intensity Therapeutics Inc. (NASDAQ:INTS) shares are trending on Friday. Check out the current price of INTS stock here. Shares of the biotechnology company rallied 394.9% in Thursday's regular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback